Overview


According to FutureWise analysis the market for microfluidic immunoassay in 2023 is US$ 1.58 billion, and is expected to reach US$ 4.17 billion by 2031 at a CAGR of 12.92%.

The microfluidic technology has recently garnered substantial interest. This is primarily owing to the reduced need of separate instruments with the integration of entire lab process on a single chip. The microfluidic system has showcased promising results in the immunosensor division. These sensors provide substantial benefits over traditional methods like high surface to volume ratio to transport efficient mass in immunoreactions. Such advancements in immunosensors and the increasing prevalence of diseases, the market is likely to showcase substantial growth during the forecast period.

Paper based microfluidics is the new microfluidic immunoassay market trend and this is mainly owing to many benefits of paper material like low cost of substrate material and which is compatible with a variety of medical applications. Furthermore, an extensive research has been conducted over paper-based microfluidics. For instance, Diagnostics for All Inc. develops paper-based LOC that costs low aiming at providing low-cost diagnostics to developing and underdeveloped nations. As the research for paper-based microfluidics has been financed heavily, it is likely to create an efficient alternative for traditional diagnostic devices over the coming years.
  • Abaxis, Inc. (a subsidiary of Zoetis Inc.)
  • Nanomix, Inc.
  • Abbott Laboratories
  • Koninklijke Philips N.V.
  • Biosurfit SA
  • Micropoint science, Inc.
  • Siloam Biosciences
  • NanoEnTek Inc.
  • OPKO Health, Inc.
  • Quidel Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Lab-on-chip/microfluidic diagnostics
    • Microfluidic Analyzers
    • MicrofluidicCartridges
  • Other Quantifiable POC diagnostics
    • POC Analyzers
    • Reagents and Assays

By Technology

  • Point of Care Lab on Chip Technology
    • Electrochemical LOC POC Technology
    • Optical POC LOC Technology
  • Non Lab on Chip Point of Care Technology

By Application

  • Cardiac Biomarker Detection
    • Single Biomarker Assay
      • Troponin
      • Brain Natriuretic Peptide (BNP)
      • Other Cardiac Biomarkers
    • Multiplexed Panel Assay
  • Inflammatory Biomarker Detection
  • Other Biomarkers
  • Emerging Biomarkers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is segregated into product, technology and region. The product segment is fragmented into microfluidic diagnostic, POC analyzers, reagent and assay. The microfluidic diagnostic segment is predicted to account for the largest microfluidic immunoassay market share during the forecast period. The microfluidic system has the cartridge as the core component that helps in integrating the storage of reagents, fluid handling components and biosensor array. Sub-components like microchannels, microfilters, microvalves, micropumps are integrated on one chip to control and analyse biological constituents at a micron level. The cost of the cartridge depends on the material type, reagent used and design type. The technology segment is bifurcated into point of care lab on chip technology and non-lab on chip point of care technology. The point of care lab on chip technology is predicted to lead the market owing to the rising demand for miniaturising the process of microfluidics and to obtain effective results.

The North America region is anticipated to dominate the market owing to the increased adoption of immunoassay technology with the emergence of lab-on-chip technology and the rising disposable income. However, the Asia Pacific region is predicted to proliferate at a quicker rate during the forecasted timeframe. With improvements in the healthcare infrastructure, rise in the innovation pertaining to microfluidics and the business expansion of key players in the region.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the global Microfluidic Immunoassay Market By Product Type, By Technology, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Microfluidic Immunoassay Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1 . Reimbursement Framework
         6.2 . Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1 . Market Driver Analysis
         1.2 . Market Restraint Analysis
         1.3 . Industry Challenges
  • 6.   Market Analysis tools
    •   1. Industry Analysis - Porter’s
         1.1 . Supplier Power
         1.2 . Buyer Power
         1.3 . Substitution Threat
         1.4 . Threat from new entrants
         1.5 . Competitive Rivalry
        2. Pestel Analysis
         2.1 . Political Landscape
         2.2 . Environmental Landscape
         2.3 . Social landscape
         2.4 . Technology landscape
         2.5 . Legal Landscape
  • 7.   Microfluidic Immunoassay Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Lab-on-chip/microfluidic diagnostics
         1.1. Microfluidic Analyzers
         1.2. MicrofluidicCartridges
        2. Other Quantifiable POC diagnostics
         2.1. POC Analyzers
         2.2. Reagents and Assays

  • 8.   Microfluidic Immunoassay Market, By Technology Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Point of Care Lab on Chip Technology
         1.1. Electrochemical LOC POC Technology
         1.2. Optical POC LOC Technology
        2. Non Lab on Chip Point of Care Technology

  • 9.   Microfluidic Immunoassay Market, By Application Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Cardiac Biomarker Detection
         1.1. Single Biomarker Assay
          1.1.1. Troponin
          1.1.2. Brain Natriuretic Peptide (BNP)
          1.1.3. Other Cardiac Biomarkers
         1.2. Multiplexed Panel Assay
        2. Inflammatory Biomarker Detection
        3. Other Biomarkers
        4. Emerging Biomarkers

  • 10.   North America Microfluidic Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.3 . Rest of North America
        3 . Market Size (USD Mn) Forecast for North America 2023-2031

  • 11.   Latin America Microfluidic Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Uruguay
         3.3 . Argentina
         3.4. Rest of Latin America
        4. Market Size (US$ Mn) Forecast for Latin America 2023-2031

  • 12.   Europe Microfluidic Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5 . Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        3. Market Size (US$ Mn) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Microfluidic Immunoassay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1 . Introduction
        2 . Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. Korea
         2.5. India
         2.6. Australia and New Zealand
         2.7. ASEAN
         2.8. Rest of Asia Pacific
        3. Market Size (US$ Mn) Forecast for Asia Pacific 2023-2031

  • 14.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Abaxis Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Nanomix, Inc.
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abbott Laboratories
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Koninklijke Philips N.V.
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Biosurfit SA
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Micropoint Bioscience, Inc
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Siloam Biosciences
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. NanoEnTek Inc
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview    
        9. OPKO Health
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Quidel Corporation
         10.1. Company Overview (HQ, Business Segments, Employee Strength)
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Impact of COVID-19

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   Competitive Intelligence and Competitive Matrix

    •   1 . Competitive Intelligence
        2 . Competitive Matrix

  • 19.   Major Deals and Strategic Alliances Analysis

    •   1 . Joint ventures
        2 . Mergers and acquisitions
        3 . Licensing and partnerships
        4 . Technology Collaborations
        5 . Strategic Divestments
        6 . Market Entry Strategies

  • 20.   Relevant Case Studies and Latest News Updates
  • 21.   Research Sources and List of Primary Contacts of this Study
  • 22.   Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11